EGX:AXPH Revenue

Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 780.08M EGP in the quarter ending December 31, 2024, with 60.35% growth. This brings the company's revenue in the last twelve months to 2.33B, up 43.23% year-over-year. In the fiscal year ending June 30, 2024, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 1.77B with 19.12% growth.

Revenue (ttm)

2.33B

Revenue Growth

+43.23%

P/S Ratio

0.88

Revenue / Employee

n/a

Employees

n/a

Market Cap

2.05B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.77B	283.76M	19.12%
Jun 30, 2023	1.48B	384.31M	34.94%
Jun 30, 2022	1.10B	-4.24M	-0.38%
Jun 30, 2021	1.10B	79.44M	7.75%
Jun 30, 2020	1.02B	195.78M	23.61%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	114.75B
El Sewedy Electric Company	231.98B
Talaat Moustafa Group Holding	42.67B
Eastern Company S.A.E	30.98B
Misr Fertilizer Production Company	19.65B
Egypt Aluminum	40.94B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	20.16B
Qatar National Bank	42.70B

Revenue Rankings